Vnitr Lek 2017, 63(11):848-859 | DOI: 10.36290/vnl.2017.158

The complications after lung transplantation

Petr Jakubec*, Monika Žurková, Lenka Hajdová, Aneta Křenková, Vítězslav Kolek
Klinika plicních nemocí a tuberkulózy LF UP a FN Olomouc

Lung transplantation (LuTx) is an important treatment for a selected group of patients in the terminal stage of a number of lung diseases, which can bring them a significant improvement in quality of life and long-term survival. Nowadays a perioperative period is not significant limitation for patient survival due to the development of transplant surgery, but the period of months to years after LuTx is crucial for survival. The post-transplant period is very complicated for LuTx patients due to a special treatment regimen, special medication, especially immunosuppressive drugs and the possibility of many complications, whether early or late or acute or chronic. These complications can be divided into several groups. These are rejections, infections, tumors, non-infectious pulmonary complications, and extrapulmonary complications. This is a very wide range of diverse states and to cope with them, it is necessary, apart from good patient co-operation, to team together with specialists in many fields of medicine. But the reward is the satisfaction, good quality of life and long-term survival of transplanted patients.

Keywords: infection; lung transplantation; rejection; tumours

Received: August 20, 2017; Accepted: September 26, 2017; Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jakubec P, Žurková M, Hajdová L, Křenková A, Kolek V. The complications after lung transplantation. Vnitr Lek. 2017;63(11):848-859. doi: 10.36290/vnl.2017.158.
Download citation

References

  1. Yusen RD, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report 2015, Focus Theme: Early Graft Failure. J Heart Lung Transplant 2015; 34(10): 1264-1277. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2015.08.014>. Go to original source... Go to PubMed...
  2. Martinu T, Pavlisko EN, Chen DF et al. Acute allograft rejection: cellular and humoral processes. Clin Chest Med 2011; 32(2): 295-310. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ccm.2011.02.008>. Go to original source... Go to PubMed...
  3. Witt CA, Gaut JP, Yusen RD et al. Acute antibody-mediation rejection after lung transplantation. J Heart Lung Transplant 2013; 32(10): 1034-1040. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2013.07.004>. Go to original source... Go to PubMed...
  4. Girnita DM, Webber SA, Zeevi A. Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation. Clin Lab Med 2008; 28: 423-440, vi. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cll.2008.08.002>. Go to original source... Go to PubMed...
  5. Christie JD, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report - 2011. J Heart Lung Transplant 2011; 30(10): 1104-1122. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2011.08.004>. Go to original source... Go to PubMed...
  6. Lowery EM, Bemiss B, Cascino T et al. Low vitamin D levels are associated with increased rejection and infections after lung transplantation. J Heart Lung Transplant 2012; 31(7): 700-707. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2012.02.012>. Go to original source... Go to PubMed...
  7. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6(1): 54-65. Dostupné z DOI: <http://dx.doi.org/10.1513/pats.200808-080GO>. Go to original source... Go to PubMed...
  8. Stewart S, Fishbein MC, Snell GI et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26(12): 1229-1242. Go to original source... Go to PubMed...
  9. Timofte I, Terrin M, Barr E et al. Belatacept for renal rescue in lung transplant patients. Transpl Int 2016; 29(4): 453-463. Dostupné z DOI: <http://dx.doi.org/10.1111/tri.12731>. Go to original source... Go to PubMed...
  10. Verleden GM, Raghu G, Meyer KC et al. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant 2014; 33(2): 127-133. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2013.10.022>. Go to original source... Go to PubMed...
  11. Christie JD, Edwards LB, Kucheryavaya AY et al. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report - 2012. J Heart Lung Transplant 2012; 31(10): 1073-1086. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2012.08.004>. Go to original source... Go to PubMed...
  12. Hachem RR, Khalifah AP, Chakinala MM et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation 2005; 80(10): 1406-1413. Go to original source... Go to PubMed...
  13. Hachem RR. Humoral responses after lung transplantation. Curr Opin Organ Transplant 2016; 21(3): 267-271. Dostupné z DOI: <http://dx.doi.org/10.1097/MOT.0000000000000308>. Go to original source... Go to PubMed...
  14. Snyder LD, Finlen-Copeland CA, Turbyfill WJ et al. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med 2010; 181(12): 1391-1396. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.200911-1786OC>. Go to original source... Go to PubMed...
  15. Allyn PR, Duffy EL, Humphries RM et al. Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation. Transplantation 2016; 100(11): 2424-2431. Go to original source... Go to PubMed...
  16. Weigt SS, Elashoff RM, Huang C et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009; 9(8): 1903-1911. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1600-6143.2009.02635.x>. Go to original source... Go to PubMed...
  17. Gregson AL, Wang X, Weigt SS et al. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med 2013; 187(5): 518-526. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201207-1228OC>. Go to original source... Go to PubMed...
  18. Hartwig MG, Anderson DJ, Onaitis MW et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg 2011; 92(2): 462-468. Dostupné z DOI: <http://dx.doi.org/10.1016/j.athoracsur.2011.04.035>. Go to original source... Go to PubMed...
  19. Sato M, Waddell TK, Wagnetz U et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30(7): 735-742. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2011.01.712>. Go to original source... Go to PubMed...
  20. Sato M, Hwang DM, Waddell TK et al. Progression pattern of restrictive allograft syndrome after lung transplantation. J Heart Lung Transplant 2013; 32(1): 23-30. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2012.09.026>. Go to original source... Go to PubMed...
  21. Jaksch P, Scheed A, Keplinger M et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012; 31(9): 950-957. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2012.05.002>. Go to original source... Go to PubMed...
  22. Kawut SM, Lederer DJ, Keshavjee S et al. Outcomes after lung retransplantation in the modern era. Am J Respir Crit Care Med 2008; 177(1): 114-120. Go to original source... Go to PubMed...
  23. Finlen-Copeland CA, Snyder LD, Zaas DW et al. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med 2010; 182(6): 784-789. Dostupné z DOI: <http://dx.doi.org/10.1164/rccm.201002-0211OC>. Go to original source... Go to PubMed...
  24. Trulock EP, Edwards LB, Taylor DO et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report - 2005. J Heart Lung Transplant 2005; 24(8): 956-967. Go to original source... Go to PubMed...
  25. Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant 2004; 4(8): 1219-1226. Go to original source... Go to PubMed...
  26. Ljungman P, Boeckh M, Hirsch HH et al. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. Clin Infect Dis 2017; 64(1): 87-91. Go to original source... Go to PubMed...
  27. Kotton CN, Kumar D, Caliendo AM et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2013; 96(4): 333-360. Dostupné z DOI: <http://dx.doi.org/10.1097/TP.0b013e31829df29d>. Go to original source... Go to PubMed...
  28. Beam E, Razonable RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr Infect Dis Rep 2012; 14(6): 633-641. Dostupné z DOI: <http://dx.doi.org/10.1007/s11908-012-0292-2>. Go to original source... Go to PubMed...
  29. Razonable RR, Humar A. [AST Infectious Diseases Community of Practice]. AST Infectious Diseases Community of Practice. Cytomegalovirus in solid organ transplantation. Am J Transplant 2013; 13(Suppl. 4): 93-106. Dostupné z DOI: <http://dx.doi.org/10.1111/ajt.12103>. Go to original source... Go to PubMed...
  30. West P, Schmiedeskamp M, Neeley H et al. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation. Transpl Infect Dis 2008; 10(2): 129-132. Go to original source... Go to PubMed...
  31. Hakki M, Chou S. The biology of cytomegalovirus drug resistance. Curr Opin Infect Dis 2011; 24(6): 605-611. Dostupné z DOI: <http://dx.doi.org/10.1097/QCO.0b013e32834cfb58>. Go to original source... Go to PubMed...
  32. Snydman DR, Limaye AP, Potena L et al. Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. Transplant Proc 2011; 43(3 Suppl): S1-S17. Dostupné z DOI: <http://dx.doi.org/10.1016/j.transproceed.2011.02.069>. Go to original source... Go to PubMed...
  33. Manuel O, Kumar D, Singer LG et al. Incidence and clinical characteristics of herpes zoster after lung transplantation. J Heart Lung Transplant 2007; 26(1): 41-47. J Heart Lung Transplant 2008; 27(1): 11-16. Dostupné z DOI: <http://dx.doi.org/10.1016/j.healun.2007.09.028>. Go to original source... Go to PubMed...
  34. Jenkins FJ, Rowe DT, Rinaldo CR. Herpesvirus infections in organ transplant recipients. Clin Diagn Lab Immunol 2003; 10(1): 1-7. Go to original source... Go to PubMed...
  35. Shah PD, Mc Dyer JF. Viral infections in lung transplant recipients. Semin Respir Cit Care Med 2010; 31(2): 243-254. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0030-1249120>. Go to original source... Go to PubMed...
  36. Remund KF, Best M, Egan JJ. Infections Relevant to Lung Transplantation. Proc Am Thorac Soc 2009; 6(1): 94-100. Dostupné z DOI: <http://dx.doi.org/10.1513/pats.200809-113GO>. Go to original source... Go to PubMed...
  37. Zaas AK, Alexander BD. New developments in the diagnosis and treatment of infections in lung transplant recipients. Respir Care Clin N Am 2004; 10(4): 531-547. Go to original source... Go to PubMed...
  38. Botha P, Archer L, Anderson RL et al. Pseudomonas aeruginosa colonisation of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome. Transplantation 2008; 85(5): 771-774. Dostupné z DOI: <http://dx.doi.org/10.1097/TP.0b013e31816651de>. Go to original source... Go to PubMed...
  39. Clark NM, Reid GE. [AST Infectious Diseases Community of Practice]. Nocardia infections in solid organ transplantation. Am J Transplant 2013; 13(Suppl 4): S83-S92. Dostupné z DOI: <http://dx.doi.org/10.1111/ajt.12102>. Go to original source... Go to PubMed...
  40. Nunley DR, Grgurich WF, Keenan RJ et al. Empyema complicating successful lung transplantation. Chest 1999; 115(5): 1312-1315. Go to original source... Go to PubMed...
  41. Husain S, Chan, KM, Palmer, SM et al. Bacteremia in lung transplant recipients in the current era. Am J Transplant 2006; 6(12): 3000-3007. Go to original source... Go to PubMed...
  42. Whiddon AR, Dawson KL, Fuentes A et al. Postoperative antimicrobials after lung transplantation and the development of multidrug-resistant bacterial and Clostridium difficile infections: an analysis of 500 non-cystic fibrosis lung transplant patients. Clin Transplant 2016; 30(7): 767-773. Dostupné z DOI: <http://dx.doi.org/10.1111/ctr.12746>. Go to original source... Go to PubMed...
  43. Pappas PG, Alexander BD, Andes DR et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50(8): 1101-1111. Dostupné z DOI: <http://dx.doi.org/10.1086/651262>. Go to original source... Go to PubMed...
  44. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18(1): 44-69. Go to original source... Go to PubMed...
  45. Weigt SS, Copeland CA, Derhovanessian A et al. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study. Am J Transplant 2013; 13(4): 919-927. Dostupné z DOI: <http://dx.doi.org/10.1111/ajt.12131>. Go to original source... Go to PubMed...
  46. Singh N, Dromer F, Perfect JR et al. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis 2008; 47(10): 1321-1327. Dostupné z DOI: <http://dx.doi.org/10.1086/592690>. Go to original source... Go to PubMed...
  47. Miller R, Assi M. [AST Infectious Diseases Community of Practice]. Endemic fungal infections in solid organ transplantation. Am J Transplant 2013; 13(Suppl 4): S250-S261. Dostupné z DOI: <http://dx.doi.org/10.1111/ajt.12117>. Go to original source... Go to PubMed...
  48. Fishman JA. Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother 1998; 42(5): 995-1004. Go to original source... Go to PubMed...
  49. Martin SI, Fishman JA. [AST Infectious Diseases Community of Practice]. Pneumocystis Pneumonia in Solid Organ Transplantation. Am J Transplant 2013; 13(Suppl 4): S272-S279. Dostupné z DOI: <http://dx.doi.org/10.1111/ajt.12119>. Go to original source... Go to PubMed...
  50. Cruciani M, Marcati P, Malena M et al. Meta-analysis of diagnostic procedures for Pneumocystis carinii pneumonia in HIV-1-infected patients. Eur Respir J 2002; 20(4): 982-989. Go to original source... Go to PubMed...
  51. Skřičková J. Pneumocystová pneumonie. Klin Farmakol Farm 2005; 19(2): 106-110.
  52. Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004; 350(24): 2487-2498. Go to original source... Go to PubMed...
  53. Alvarez-Martínez MJ, Miró JM, Valls ME et al. Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microb Infect Dis 2006; 56(2): 153-160. Go to original source... Go to PubMed...
  54. Huang L, Morris A, Limper AH et al. An Official ATS Workshop Summary: Recent Advances and Future Directions in Pneumocystis Pneumonia (PCP). Proc Am Thorac Soc 2006; 3(8): 655-664. Go to original source... Go to PubMed...
  55. Mansharamani NG, Garland R, Delaney D et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118(3): 704-711. Go to original source... Go to PubMed...
  56. Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25(2): 264-296. Dostupné z DOI: <http://dx.doi.org/10.1128/CMR.05013-11>. Go to original source... Go to PubMed...
  57. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80(2 Suppl): S254-S264. Go to original source... Go to PubMed...
  58. Engels EA, Pfeiffer RM, Fraumeni JF Jr et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306(17): 1891-1901. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2011.1592>. Go to original source... Go to PubMed...
  59. Swerdlow SH, Campo E, Harris NL et al. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. IARC WHO Classification of Tumours, No 2: Lyon 2008. ISBN 9789283224310.
  60. Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc 2009; 6(1): 79-93. Dostupné z DOI: <http://dx.doi.org/10.1513/pats.200808-094GO>. Go to original source... Go to PubMed...
  61. Hasegawa T, Iacono AT, Orons PD et al. Segmental nonanastomotic bronchial stenosis after lung transplantation. Ann Thorac Surg 2000; 69(4): 1020-1024. Go to original source... Go to PubMed...
  62. Moreno P, Alvarez A, Algar FJ et al. Incidence, management and clinical outcomes of patients with airway complications following lung transplantation. Eur J Cardiothorac Surg 2008; 34(6): 1198-1205. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ejcts.2008.08.006>. Go to original source... Go to PubMed...
  63. Marulli G, Loy M, Rizzardi G et al. Surgical treatment of posttransplant bronchial stenoses: case reports. Transplant Proc 2007; 39(6): 1973-1975. Go to original source... Go to PubMed...
  64. Kapoor BS, May B, Panu N et al. Endobronchial stent placement for the management of airway complications after lung transplantation. J Vasc Interv Radiol 2007; 18(5): 629-632. Go to original source... Go to PubMed...
  65. Diez Martinez P, Pakkal M, Prenovault J et al. Postoperative imaging after lung transplantation. Clin Imaging 2013; 37(4): 617-623. Dostupné z DOI: <http://dx.doi.org/10.1016/j.clinimag.2013.02.008>. Go to original source... Go to PubMed...
  66. Ryu JH, Doerr CH, Fisher SD et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123(2): 623-627. Go to original source... Go to PubMed...
  67. Ofek E, Sato M, Saito T et al. Restrictive allograft syndrome post lung transplantation is characterized by pleuroparenchymal fibroelastosis. Mod Pathol 2013; 26(3): 350-356. Dostupné z DOI: <http://dx.doi.org/10.1038/modpathol.2012.171>. Go to original source... Go to PubMed...
  68. Berk Y, van der Bij W, Erasmus ME et al. Non-invasive ventilation in phrenic nerve dysfunction after lung transplantation: an attractive option. J Heart Lung Transplant 2006; 25(12): 1483-1485. Go to original source... Go to PubMed...
  69. Luckraz H, Zagolin M, McNeil K et al. Graft-versus-host disease in lung transplantation: 4 case reports and literature review. J Heart Lung Transplant 2003; 22(6): 691-697. Go to original source... Go to PubMed...
  70. Wang WL, Yu LX. Acute respiratory distress attributed to sirolimus in solid organ transplant recipients. Am J Emerg Med 2015; 33(1): 124.e1-e4. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ajem.2014.05.047>. Go to original source... Go to PubMed...
  71. Silverborn M, Jeppsson A, Mårtensson G et al. New-onset cardiovascular risk factors in lung transplant recipients. J Heart Lung Transplant 2005; 24(10): 1536-1543. Go to original source... Go to PubMed...
  72. Kamdar F, Hertz M, Shumway S et al. Late effusive-constrictive pericarditis after lung transplantation. Am J Med 2015; 128(6): e1-e2. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2014.12.017>. Go to original source... Go to PubMed...
  73. Hackman KL, Snell GI, Bach LA. Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study. Diabetes Care 2014; 37(11): 2919-2925. Dostupné z DOI: <http://dx.doi.org/10.2337/dc14-0663>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.